3D Bioprinting In Pharmacognosy: A Future Tool for Conservation and Production of Bioactive Phytocompounds

Pharmacognosy plays a pivotal role in identifying, extracting, and standardizing bioactive phytocompounds that form the basis of numerous modern and traditional medicines. However, challenges such as overharvesting, habitat loss, climate change, and long growth cycles hinder sustainable production of medicinal plants. 3D bioprinting, an advanced additive manufacturing technology, offers a novel approach to plant tissue engineering by enabling precise spatial organization of plant cells within custom bioinks for scalable, controlled phytochemical synthesis. This review explores the intersection of 3D bioprinting and pharmacognosy, highlighting its potential in conservation of endangered medicinal plants, optimization of secondary metabolite production, and development of customized phytomedicine delivery systems. We discuss key bioprinting modalities inkjet, extrusion-based, and laser-assisted and their adaptation for plant cells, along with bioink formulations tailored for viability, differentiation, and metabolite yield. Case studies demonstrate successful production of high-value compounds such as paclitaxel, vincristine, and artemisinin from bioprinted plant constructs. Advantages over conventional plant tissue culture include improved reproducibility, scalability, and reduced environmental dependence. The review also addresses challenges in bioink optimization, large-scale manufacturing, cost, and regulatory frameworks. Future prospects encompass AI-guided construct design, portable on-demand phytochemical production in remote or space environments, and integration with synthetic biology for programmable metabolite pathways. By converging biotechnology, additive manufacturing, and traditional pharmacognosy, 3D bioprinting holds promise as a transformative tool for sustainable drug development and biodiversity preservation.